Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/06/2011 | US8012950 Using tartrate-resistant acid phosphatase activity as diagnostic indicator of degenerative ligament disease; bioassay |
09/06/2011 | US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell |
09/06/2011 | US8012770 Device for detection of antigens and uses thereof |
09/06/2011 | US8012769 Thyroid analyte detection and measurement |
09/06/2011 | US8012761 Using shift in spectral absorption of colorant, instigated via oxidation, as indicator of formaldehyde presence in urine |
09/06/2011 | US8012760 Sensor for direct measurement of carbonate ions in seawater |
09/06/2011 | US8012758 Monitor paper making or hydroentangling non-woven process stream; sample and analyze fluid with dissolved oxygen probe, oxidation reduction potential probe |
09/06/2011 | US8012755 Water quality evaluation method and substrate contacting apparatus used |
09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
09/06/2011 | US8012745 Assay cartridges and methods of using the same |
09/06/2011 | US8012743 Detection of target analytes using particles and electrodes |
09/06/2011 | US8012742 Buffy coat tube and float system and method |
09/06/2011 | US8012720 Protein detecting device |
09/06/2011 | US8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones |
09/06/2011 | US8012709 Method for determining if a subject having type II diabetes has a kidney disorder |
09/06/2011 | US8012707 MN gene and protein |
09/06/2011 | US8012706 Methods for detecting virulent Plasmodium, for evaluating Plasmodium virulence, and for screening new drugs employing the 3′UTR of Plasmodium SUB2 and the Plasmodium SUB2 serine protease |
09/06/2011 | US8012705 Nonseparation assay methods |
09/06/2011 | US8012704 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
09/06/2011 | US8012703 Microarrays and uses therefor |
09/06/2011 | US8012702 H+-gated ion channel |
09/06/2011 | US8012701 Agonists of bitter taste receptors and uses thereof |
09/06/2011 | US8012700 Assays for preimplantation factor and preimplantation factor peptides |
09/06/2011 | US8012699 Recombinant antigens for diagnosis and prevention of murine typhus |
09/06/2011 | US8012698 Diagnostic markers of wound infection |
09/06/2011 | US8012697 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
09/06/2011 | US8012696 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
09/06/2011 | US8012695 Methods and compositions relating to promoter regulation by MUC1 and KLF proteins |
09/06/2011 | US8012694 Assay for the detection of phosphorylated PTH |
09/06/2011 | US8012693 Analysis of chemically crosslinked cellular samples |
09/06/2011 | US8012692 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD |
09/06/2011 | US8012686 Risk assessment for adverse drug reactions |
09/06/2011 | US8012685 Detection of analytes and nucleic acids |
09/06/2011 | US8012678 Biomarkers for human papilloma virus-associated cancer |
09/06/2011 | US8012587 hydrophilic polymer layers bound by means of adhesion promoters, used as immobilization matrix and for the suppression of non-specific protein adsorption in biosensors, MALDI targets and other bioanalytical devices |
09/06/2011 | US8012483 Phosphorylcholine conjugates and corresponding antibodies |
09/06/2011 | US8012480 Detection of proteins from circulating neoplastic cells |
09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
09/06/2011 | US8012458 Rare-earth amidate coordination compounds |
09/06/2011 | US8012456 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom |
09/06/2011 | US8012434 Anti-clogging device and method for in-gel digestion applications |
09/06/2011 | US8012429 Hermetic sealed radiation transparent container with powder; colormetric analysis; water qualitative analysis |
09/06/2011 | US8012421 For monitoring a concentration of a plurality of use solutions, each solutions being,a concentrate in a diluent and having a resistivity which varies as a function of both temperature and an amount of the concentrate contained in a given amount of the diluent |
09/06/2011 | US8011238 Method for correcting the measured concentrations of gas components in drilling mud |
09/06/2011 | US8011228 Method for the detection of lateral flow assay and strip and laser-induced epifluorescence and compact scanner therefor |
09/06/2011 | US8011223 Remaining hydrogen sensor |
09/06/2011 | CA2654733C Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
09/06/2011 | CA2515891C Ft-nir fatty acid determination method |
09/06/2011 | CA2488483C Analytical sandwich test for determining nt-probnp |
09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
09/06/2011 | CA2451373C Monitoring of gas sensors |
09/06/2011 | CA2450266C Long-term urine collection system |
09/06/2011 | CA2431864C Elemental analysis of tagged biologically active materials |
09/06/2011 | CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
09/06/2011 | CA2335230C Regions of papilloma virus e1 helicase involved in e1 oligomerization |
09/01/2011 | WO2011106746A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
09/01/2011 | WO2011106723A2 Anti-paf antibodies |
09/01/2011 | WO2011106709A2 Epithelial biomarkers for cancer prognosis |
09/01/2011 | WO2011106693A2 Microscale western blot |
09/01/2011 | WO2011106676A2 Methods of human embryonic stem cell growth |
09/01/2011 | WO2011106611A2 System and method for anatomical pathology sample handling, storage, and analysis |
09/01/2011 | WO2011106583A1 Polytag probes |
09/01/2011 | WO2011106558A1 Methods for autoimmune disease diagnosis, prognosis, and treatment |
09/01/2011 | WO2011106556A2 Systems and methods for adaptive recursive sequencing |
09/01/2011 | WO2011106536A2 Methods of diagnosing infectious disease pathogens and their drug sensitivity |
09/01/2011 | WO2011106456A2 Artificial mycolic acid membranes |
09/01/2011 | WO2011106451A1 Methods of treating metal oxide surfaces and surfaces produced thereby |
09/01/2011 | WO2011106402A1 Method and system for detecting fluorochromes in a flow cytometer |
09/01/2011 | WO2011106401A2 Methods and compositions relating to multiciliate cell differentiation |
09/01/2011 | WO2011106396A1 Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios |
09/01/2011 | WO2011106373A2 Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells |
09/01/2011 | WO2011106363A2 Metabolic rate indicator for cellular populations |
09/01/2011 | WO2011106322A2 Biomarkers for acute ischemic stroke |
09/01/2011 | WO2011106315A1 Self-contained biological assay apparatus, methods, and applications |
09/01/2011 | WO2011106272A1 Novel binding assays useful in identifying antibodies with altered half-lives |
09/01/2011 | WO2011106255A1 Fluidic devices having incorporated electrodes |
09/01/2011 | WO2011106214A1 Laminated electrochemical sensor with controlled variation of working electrode |
09/01/2011 | WO2011106088A2 Systems and methods for evaluating asphaltene deposition inhibitors |
09/01/2011 | WO2011106084A1 Cancer patient selection for administration of therapeutic agents using mass spectral analysis |
09/01/2011 | WO2011106057A2 Nanostructure biosensors and systems and methods of use thereof |
09/01/2011 | WO2011106044A1 Device for and method of extracting a fraction from a biological sample |
09/01/2011 | WO2011106039A1 Arylpiperazone opioid receptor antagonists |
09/01/2011 | WO2011105968A2 A cell based system for rapid detection and quantification of genotoxicity |
09/01/2011 | WO2011105847A2 Apparatus for analyzing cancer cells using cell surface microstructure analysis |
09/01/2011 | WO2011105826A2 Method using camp expression measurement to diagnose prostate inflammation, and diagnostic kit |
09/01/2011 | WO2011105820A2 Enzyme column and method for manufacturing same |
09/01/2011 | WO2011105732A2 Method and kit for detecting egfr mutation by using pna-based real-time pcr clamping |
09/01/2011 | WO2011105721A9 Preparation method of antigen-immobilized immunofluorescence slide, and immunofluorescence slide prepared thereby |
09/01/2011 | WO2011105721A2 Preparation method of antigen-immobilized immunofluorescence slide, and immunofluorescence slide prepared thereby |
09/01/2011 | WO2011105668A1 Fluid viscosity measuring device |
09/01/2011 | WO2011105654A1 Y-probe and variation thereof, and dna microarray, kit, and gene analysis method using the y-probe and the variation thereof |
09/01/2011 | WO2011105617A1 Method for predicting activity of chemical substance |
09/01/2011 | WO2011105573A1 Anti-icam3 antibody and use thereof |
09/01/2011 | WO2011105570A1 Method for determining presence or absence of cancer cell in biological sample, and molecular marker and kit for determination |
09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
09/01/2011 | WO2011105544A1 Tumor marker, antibody to same, detection kit for same, and method for detecting same |
09/01/2011 | WO2011105537A1 Sample extract that minimizes false positive reaction |
09/01/2011 | WO2011105527A1 Nerve growth promoter |
09/01/2011 | WO2011105507A1 Cell analyzer |